Fairmount Funds Management Llc - Net Worth and Insider Trading

Over the past 18 months, Fairmount Funds Management Llc made 1 insider transaction in Cogent Biosciences Inc (COGT) with a net purchase of 800,000.

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Fairmount Funds Management Llc made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,626,400 shares, with a net purchase of 1,626,400 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,092,794 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Fairmount Funds Management Llc made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .

In summary, during the past 3 months, insiders sold 25,531 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 25,531 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Fairmount Funds Management Llc made no insider transaction in Apogee Therapeutics Inc (APGE). Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net sale of 150,000 shares made by Michael Thomas Henderson , a net sale of 33,325 shares made by Carl Dambkowski , and a net purchase of 2,941,176 shares made by Fairmount Healthcare Fund L.p. .

In summary, during the past 3 months, insiders sold 114,995 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 114,995 shares. During the past 18 months, 189,325 shares of Apogee Therapeutics Inc (APGE) were sold and 4,691,176 shares were bought by its insiders, resulting in a net purchase of 4,501,851 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.